Investors can speculate about the future of a stock by watching how its insiders buy and sell stocks. Madrigal Pharmaceuticals Inc shares valued at $2,564,426 were sold by CRAVES FRED B on Mar 12 ’25. At $331.84 per share, CRAVES FRED B sold 7,728 shares. The insider’s holdings dropped to 350,076 shares worth approximately $104.63 million following the completion of this transaction.
Also, CRAVES FRED B sold 7,742 shares, netting a total of over 2,518,053 in proceeds. Following the sale of shares at $325.25 each, the insider now holds 350,076 shares.
Before that, FRED CRAVES had added 7,742 shares to its account. In a trade valued at $2,518,054, the Director bought Madrigal Pharmaceuticals Inc shares for $325.25 each.
As published in a research note from B. Riley Securities on February 28, 2025, Madrigal Pharmaceuticals Inc [MDGL] has been rated up from a Neutral to a Buy and the price target has been revised to $422 from $236. Analysts at H.C. Wainwright resumed the stock at ‘”a Buy”‘ outlook in a report released in late February. As of June 28, 2024, Cantor Fitzgerald has initiated its “Neutral” rating for MDGL. Earlier on June 11, 2024, Wolfe Research initiated its rating. Their recommendation was “an Outperform” for MDGL stock.
Analyzing MDGL Stock Performance
On last trading session, Madrigal Pharmaceuticals Inc [NASDAQ: MDGL] plunged -0.43% to $298.87. The stock’s lowest price that day was $298.0, but it reached a high of $304.0 in the same session. During the last five days, there has been a drop of approximately -0.21%. Over the course of the year, Madrigal Pharmaceuticals Inc shares have jumped approximately 7.00%. Shares of the company reached a 52-week high of $377.46 on 02/26/25 and a 52-week low of $265.00 on 05/27/25.
Support And Resistance Levels for Madrigal Pharmaceuticals Inc (MDGL)
According to the 24-hour chart, there is a support level at 296.58, which, if violated, would cause prices to drop to 294.29. In the upper region, resistance lies at 302.58. The next price resistance is at 306.29. RSI (Relative Strength Index) is 56.27 on the 14-day chart, showing neutral technical sentiment.
Is Madrigal Pharmaceuticals Inc subject to short interest?
Stocks of Madrigal Pharmaceuticals Inc saw a sharp rise in short interest on 2025-06-13 jumping by 0.15 million shares to 4.15 million. Data from Yahoo Finance shows that the short interest on 2025-05-15 was 4.0 million shares. A jump of 3.65% in short interest reflects a negative sentiment towards the stock. Despite the fact that short shares comprise just 13.32 of the overall float, the days-to-cover ratio (short ratio) jumped to 13.32.
Which companies own the most shares of Madrigal Pharmaceuticals Inc (MDGL)?
In terms of Madrigal Pharmaceuticals Inc share price expectations, FactSet research, analysts set an average price target of 420 in the next 12 months, up nearly 39.93% from the previous closing price of $300.15. Analysts anticipate Madrigal Pharmaceuticals Inc stock to reach 420 by 2025, with the lowest price target being 420. In spite of this, 11 analysts ranked Madrigal Pharmaceuticals Inc stock as Buy at the end of 2025. On April 22, 2024, BofA Securities assigned a price target of “an Underperform” to the stock and initiated coverage with a $150.
